Alendronate  Tablets

70 mg



Alendronate belongs to the therapeutic group of bisphosphonates which slow bone loss. The product is indicated for treatment and prevention of osteoporosis.
Unipharm’s generic Alendronate Tablets have been manufactured and marketed in Israel since 2004.

  • ATC4: M05BA
  • Strengths: 70 mg
  • Dosage form: Tablets
  • Out-licensing is offered for all international markets*
  • Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect

related products